Bibliographic Citation
| - Biegstraaten M., ArngrÃmsson R., Barbey F., Boks L., Cecchi F., Deegan P.B., Feldt-Rasmussen U., Geberhiwot T., Germain D.P., Hendriksz C., Hughes D.A., Kantola I., Karabul N., Lavery C., Linthorst G.E., Mehta A., van de Mheen E., Oliveira J.P., Parini R., Ramaswami U., Rudnicki M., Serra A., Sommer C., Sunder-Plassmann G., Svarstad E., Sweeb A., Terryn W., Tylki-Szymanska A., Tøndel C., Vujkovac B., Weidemann F., Wijburg F.A., Woolfson P., Hollak C.E.. Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document.2015.
|